GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving ...

The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

Biopharmaceuticals (biologics) are complex drugs made from living sources, not chemical processes. The government is planning ...

The global bio-pharmaceutical market is projected to surge to approximately 1,400 trillion won in about two years. Bio-pharmaceuticals refer to medicines made from biological materials such as human ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition. The ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

The last year has been a stellar one for the biotechnology industry. The industry has easily outperformed the market, with all of its indices, including the Amex Biotechnology Index ETF (FBT), the ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

This news release contains certain forward-looking statements relating to STARJEMZA ® /BAT2206 or the product pipelines in general of Bio-Thera Solutions and Hikma. Readers are strongly cautioned that ...

As part of the plan, Finance Minister Nirmala Sitharaman proposed 'Bio Pharma Shakti', a dedicated outlay of Rs 5,000 crore over five years, to accelerate capacity building and support advanced ...

HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation ...